Jade Biosciences, Inc.
NASDAQ:JBIOBiotechnology
Healthcare
$15.49 -1.25%
-$0.21 today
- Market cap
- $1.07B
- Beta
- 1.45
- P/E (TTM)
- -7.4
- EPS (TTM)
- -$2.24
52W Low $6.67High $28.00
Volume 0.79M
Average 0.83M
Price history
Jade Biosciences, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+24.32%
Period high
$26.85
Period low
$11.48
Latest
$15.49
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 13, 2026 | Nov 13, 2026 | |
| 8-K | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G | Oct 27, 2026 | Oct 27, 2026 | |
| 424B5 | Jun 3, 2026 | Jun 3, 2026 | |
| 8-K | Jun 1, 2026 | Jun 1, 2026 | |
| EFFECT | May 15, 2026 | May 18, 2026 | |
| SC 13G/A | May 15, 2026 | May 15, 2026 | |
| EFFECT | May 15, 2026 | May 18, 2026 | |
| 424B3 | May 15, 2026 | May 15, 2026 | |
| S-3 | May 7, 2026 | May 7, 2026 | |
| 424B3 | May 7, 2026 | May 7, 2026 | |
| S-3 | May 7, 2026 | May 7, 2026 | |
| 8-K | May 7, 2026 | May 7, 2026 | |
| 10-Q | May 7, 2026 | May 7, 2026 |
Competitors
Who does Jade Biosciences, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about JBIO's filings, answered from its disclosures.
What is the latest JBIO filing?
The latest filing shown is 8-K dated Nov 13, 2026.
How many recent filings does JBIO have?
Intrinsic Alpha currently shows 20 recent filings for JBIO.
Continue the stock analysis
Jump to another research area for this company.